The effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro

Tekisogullari K., Topcul M. R.

JOURNAL OF BUON, vol.18, no.1, pp.253-260, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 1
  • Publication Date: 2013
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.253-260
  • Keywords: apoptotic index, cancer, mitotic index, sunitinib, sutent, targeted cancer therapy, TYROSINE KINASE INHIBITOR, TELOMERE DYSFUNCTION, SU11248, ANGIOGENESIS, MECHANISMS, GROWTH, FUSION
  • Istanbul University Affiliated: Yes


Purpose: In this study, the antiproliferative and apoptotic effects of sunitinib (SU-11248, Sutent) which is used for targeted therapy was evaluated on HeLa cell line originated from human cervix carcinoma.